Stockreport

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA) [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Itvisma demonstrated clinically meaningful and statistically significant improvement in motor function in Phase III STEER study One-time dose of Itvisma replaces SMN1 [Read more]